Replies to post #99729 on Innovation Pharmaceuticals Inc (IPIX)

[GregChase]

I wonder if the FDA is the "appropriate scientific venue"

listed in the corporate update

"The Company is saving the full p21 results for an appropriate scientific venue"

[WellSpring]

That was my thought [hope] when they initially posted it on their FB a few days ago. This furthers my speculation, but alas it is still speculation.

[BonelessCat]

Anecdotal evidence does point to efficacy against at least one type ovarian cancer. There is the woman who reportedly had 7 cycles of Kevetrin, all below 50 mg/m^2. Before a patient can receive an additional cycle there must be a perceived benefit, whatever "perceived benefit" might mean. I'm also thinking a possible trial against pancreatic cancer, though Ovarian was the only example given.